Could a diabetes drug help people with HIV lose weight and fight inflammation?
NCT ID NCT06935838
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study tests if tirzepatide, a weekly injection, can help 12 overweight or obese adults with well-controlled HIV lose weight and reduce chronic inflammation. Participants will receive increasing doses over 12 weeks, and researchers will track body weight, body composition, liver fat, and inflammatory markers. The goal is to see if this approach can improve health outcomes in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
John A Burns School of Medicine
RECRUITINGHonolulu, Hawaii, 96813, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.